Want to join the conversation?
In 1Q16, for $LH's LabCorp Diagnostics segment, revenue was $1.6Bil, an increase of 7.2% over last year. The increase in revenue was the result of organic volume growth, Beacon LBS, price, mix and tuck-in acquisitions, partially offset by currency. For Covance Drug Development, revenue was $703MM, an increase of 12.6% over last year.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !